Recommendations for Use
After the deliberate anthrax attacks made on the U.S. Postal Service in 2001, the Centers for Disease Control and Prevention (CDC) expanded the Advisory Committee on Immunization Practices (ACIP) recommendations from 200011 for the use of anthrax vaccine in the United States.
In the Supplemental Recommendations12, the ACIP:
- Reaffirms that pre-exposure use of anthrax vaccine should be based on a quantifiable risk for exposure
- Recommends that groups at high risk for repeated exposures to Bacillus anthracis spores should be given priority for pre-exposure vaccination
11 Centers for Disease Control and Prevention. The Use of Anthrax Vaccines in the United States: Recommendations of the Advisory Committee of Immunization Practices (ACIP). MMWR. 2000;49(RR-15):1-20.
12 Centers for Disease Control and Prevention. Notice to readers: Use of Anthrax Vaccine in Response to Terrorism, Supplemental Recommendations of the Advisory Committee on Immunization Practices. MMWR. 2002;51(45):1024-1026.
